Literature DB >> 6618859

Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports.

L Rossi, U Bonuccelli, G Marcacci, A Bindi, G De Scisciolo, R Arena.   

Abstract

Gynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered. The common systemic diseases that may give rise to gynecomastia were excluded. One of the patients presented hyperprolactinemia and a raised estrogen/androgen ratio but the hormone levels were not raised in the other. The onset of symptoms after fluorescence in both cases is highly suggestive, although the pathogenetic mechanism is not clear.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618859     DOI: 10.1007/bf02043907

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  7 in total

1.  Serum prolactin levels in patients with gynecomastia.

Authors:  R W Turkington
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958

2.  Increased oestradiol in diazepam related gynaecomastia.

Authors:  D Bergman; W Futterweit; R Segal; D Sirota
Journal:  Lancet       Date:  1981-11-28       Impact factor: 79.321

3.  Normoprolactinemia in boys with marked gynecomastia.

Authors:  W Beck
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

Review 4.  Gynecomastia.

Authors:  H E Carlson
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

5.  Hyperprolactinaemia and impotence.

Authors:  S Franks; H S Jacobs; N Martin; J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1978-04       Impact factor: 3.478

6.  Sex hormone changes in male epileptics.

Authors:  B K Toone; M Wheeler; P B Fenwick
Journal:  Clin Endocrinol (Oxf)       Date:  1980-04       Impact factor: 3.478

7.  [Clinical and electroencephalographic observations on the action of new antiepileptic drug: "Caducid Wassermann" (p-fluorophenylethylsulfone)].

Authors:  F Maccagnani
Journal:  Riv Neurol       Date:  1966 Jul-Aug
  7 in total
  3 in total

Review 1.  Gynecomastia and drugs: a critical evaluation of the literature.

Authors:  Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal:  Eur J Clin Pharmacol       Date:  2015-04-02       Impact factor: 2.953

2.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

3.  Author's Reply: The curious case of prolactin hormone.

Authors:  Mohammad Abid Keen; Iffat Hassan
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.